Articles dans des revues avec comité de lecture (14)
  1. 1. Gemander, N., Kemlin, D., Depickère, S., Kelkar, N. N., Pannus, P., Sharma, S., Waegemans, A., Olislagers, V., Georges, D., Dhondt, E., Braga, M., Heyndrickx, L., Michiels, J., Thiriard, A., Lemy, A., Vandevenne, M., Goossens, M. M., Matagne, A., Desombere, I., Ariën, K., Ackerman, M. M., Le Moine, A., & Marchant, A. (2024). Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients. Kidney International Reports, 9(3), 635-648. doi:10.1016/j.ekir.2023.12.008
  2. 2. Sharma, S., Thiriard, A., Olislagers, V., Lechien, J. R., Jurion, M.-H., Delforge, M.-L., Marchant, A., & Saussez, S. (2024). Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction. Journal of medical virology, 96(1), e29398. doi:10.1002/jmv.29398
  3. 3. Pannus, P., Depickère, S., Kemlin, D., Georges, D., Houben, S., Olislagers, V., Waegemans, A., De Craeye, S., Francotte, A., Chaumont, F., Van Oostveldt, C., Heyndrickx, L., Michiels, J., Willems, E., Dhondt, E., Krauchuk, M., Schmickler, M.-N., Verbrugghe, M., Van Loon, N., Dierick, K., Matagne, A., Desombere, I., Ariën, K. K., Marchant, A., & Goossens, M. M. (2023). Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults. Vaccine, 41(17), 2829-2836. doi:10.1016/j.vaccine.2023.03.047
  4. 4. Kemlin, D., Gemander, N., Depickère, S., Olislagers, V., Georges, D., Waegemans, A., Pannus, P., Lemy, A., Goossens, M. M., Desombere, I., Michiels, J., Vandevenne, M., Heyndrickx, L., Ariën, K. K., Matagne, A., Ackerman, M. M., Le Moine, A., & Marchant, A. (2023). Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients. American Journal of Transplantation. doi:10.1016/j.ajt.2023.02.015
  5. 5. Tomasi, L., Thiriard, A., Heyndrickx, L., Georges, D., Van den Wijngaert, S., Olislagers, V., Sharma, S., Matagne, A., Ackerman, M. M., Ariën, K. K., Goetghebuer, T., & Marchant, A. (2022). Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection. Open Forum Infectious Diseases, 9(11), ofac554. doi:10.1093/ofid/ofac554
  6. 6. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  7. 7. Brauns, E., Azouz, A., Grimaldi, D., Xiao, H., Thomas, S., Nguyen, M., Olislagers, V., Vu Duc, I., Orte Cano, C., Del Marmol, V., Pannus, P., Libert, F., Saussez, S., Dauby, N., Das, J., Marchant, A., & Goriely, S. (2022). Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19. JCI insight, 7(9). doi:10.1172/jci.insight.154183
  8. 8. Pannus, P., Depickère, S., Kemlin, D., Houben, S., Neven, K. Y., Heyndrickx, L., Michiels, J., Willems, E., De Craeye, S., Francotte, A., Chaumont, F., Olislagers, V., Waegemans, A., Verbrugghe, M., Schmickler, M.-N., Van Gucht, S., Dierick, K., Marchant, A., Desombere, I., Ariën, K. K., & Goossens, M. M. (2022). Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial. PLOS global public health, 2(12), e0001308. doi:10.1371/journal.pgph.0001308
  9. 9. Saussez, S., Sharma, S., Thiriard, A., Olislagers, V., Vu Duc, I., Le Bon, S.-D., Khalife, M., Hans, S., De Riu, G., Hopkins, C., Lechien, J., Vaira, L., & Marchant, A. (2021). Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. European journal of neurology, 28(11), 3702-3711. doi:10.1111/ene.14994
  10. 10. Huygens, A., Appay, V., donner, C., Marchant, A., Lecomte, S., Tackoen, M., Olislagers, V., Delmarcelle, Y., Burny, W., Van Rysselberge, M., Liesnard, C., & Larsen, M. R. (2015). Functional Exhaustion Limits CD4+ and CD8+ T-Cell Responses to Congenital Cytomegalovirus Infection. The Journal of infectious diseases, 212(3), 484-494. doi:10.1093/infdis/jiv071
  11. 11. Antoine, P., Olislagers, V., Huygens, A., Lecomte, S., Liesnard, C., donner, C., & Marchant, A. (2012). Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection. The Journal of immunology, 189(5), 2665-2672. doi:10.4049/jimmunol.1101165
  12. 12. De Wit, D., Olislagers, V., Goriely, S., Vermeulen, F., Wagner, H., Goldman, M., & Willems, F. (2004). Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood, 103(3), 1030-1032. doi:10.1182/blood-2003-04-1216
    13. << Précédent 1 2 Suivant >>